Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices.


BACKGROUND The use of arteriotomy closure devices (CDs) to achieve hemostasis after femoral artery access in percutaneous coronary intervention is steadily increasing. However, the safety information with these devices in the era of triple antiplatelet therapy is limited. METHODS We reviewed prospectively collected data from the Do Tirofiban and ReoPro… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics